NATIONAL CLINICAL RECOMMENDATIONS FOR DIAGNOSIS AND THERAPY OF IDIOPATHIC THROMBOCYTOPENIC PURPURA (PRIMARY IMMUNE THROMBOCYTOPENIA) IN ADULTS

被引：0

作者：

Melikyan, A. L. ^{[1
]}

Pustovaya, E., I ^{[1
]}

Tsvetaeva, N., V ^{[1
]}

Gritsaev, S., V ^{[1
]}

Pospelova, T., I ^{[3
]}

Lisukov, I. A. ^{[4
]}

Davydkin, I. L. ^{[5
]}

Golenkov, A. K. ^{[6
]}

Ivanova, V. L. ^{[7
]}

Shatokhin, Yu, V ^{[8
]}

Abdulkadyrov, K. M. ^{[2
]}

Savchenko, V. G. ^{[1
]}

机构：

[1] Hematol Res Ctr, Moscow 125167, Russia

[2] Russian Inst Hematol & Transfusiol, St Petersburg 191024, Russia

[3] Novosibirsk State Med Univ, Novosibirsk 630091, Russia

[4] II Metchnikov North West State Med Univ, Ctr Oncohematol & Transplantol, St Petersburg 194156, Russia

[5] Samara State Med Univ, Samara 443099, Russia

[6] NF Vladimirsky Moscow Reg Res & Clin Inst, Moscow 129110, Russia

[7] SP Botkin Municipal Clin Hosp, Hematol Municipal Ctr, Moscow 125284, Russia

[8] Rostov State Med Univ, Rostov Na Donu 344019, Russia

来源：

GEMATOLOGIYA I TRANSFUZIOLOGIYA | 2015年 / 60卷 / 01期

关键词：

idiopathic thrombocytopenic purpura; primary and secondary immune thrombocytopenia; anti-platelet antibodies; first-; second-; and third-line therapies; glucocorticosteroids; immunoglobulins; thrombopoietin mimetics; splenectomy; pregnancy and idiopathic thrombocytopenic purpura; THROMBOPOIESIS-STIMULATING PEPTIBODY; HIGH-DOSE DEXAMETHASONE; LONG-TERM TREATMENT; PLATELET COUNTS; SPLENECTOMY; ELTROMBOPAG; MANAGEMENT; ROMIPLOSTIM; EFFICACY; AMG-531;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The research group for studies of idiopathic thrombocytopenic purpura (ITP) has developed clinical recommendations for the diagnosis and treatment of this disease. The aim of the recommendations is standardization of the diagnostic and therapeutic approaches in Russia. The current methodological approaches proceed from the conclusive medicine philosophy and are based on the recommendations of the Russian Expert Council for the diagnosis and therapy of patients with primary immune thrombocytopenia and the experience gained in the treatment of ITP patients (primary immune thrombocytopenia) in Russia, as well as on recommendations of the International Working Group for studies of primary immune thrombocytopenia, decisions of the International Consensus on ITP diagnosis and therapy, and recommendations of the European and American Societies of Hematologists for ITP studies. The recommendations are developed by the multicenter research group for ITP studies. Working groups from 8 leading institutions of Russia contributed to the development of clinical recommendations.

引用

页码：44 / 56

页数：17

共 72 条

[1] Prospective screening of 205 patients with ITP, including diagnosis, serological markers, and the relationship between platelet counts, endogenous thrombopoietin, and circulating antithrombopoietin antibodies [J].